Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Epizyme, Inc. (NASDAQ: EPZM) to Ipsen is fair to Epizyme shareholders. Halper Sadeh encourages Epizyme shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or
[email protected] or
[email protected] . The investigation concerns whether Epizyme and its board of directors violated the federal securities laws and/or...